Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Panacea Biotec Ltd. Board/Management Information 2024

Apr 29, 2024

62573_rns_2024-04-29_9aaf7add-aa7f-42af-96ca-a1fbe88369ea.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [142 x 65] intentionally omitted <==

April 29, 2024

The Manager, Listing Department BSE Limited The National Stock Exchange of India Ltd. Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai - 400 051 Dalal Street, Mumbai - 400 001 NSE Symbol: PANACEABIO BSE Scrip Code: 531349

Sub.: Intimation regarding resignation of Senior Management Personnel of the Company’s material subsidiary viz. Panacea Biotec Pharma Limited (“PBPL”)

Re: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Dear Sir / Madam,

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we would like to inform you that Mr. Sanjay Kumar, Sr. General Manager - Quality (Pharma & Oncology) of the Company’s material subsidiary, Panacea Biotec Pharma Limited (“Senior Management Personnel of Material Subsidiary”) has vide its letter dated March 10, 2024 tendered his resignation with a request to relieve him from the duties on March 31, 2024, due to personal reasons.

PBPL has accepted his resignation and relieved him from the duties accordingly.

Further, disclosure required pursuant SEBI Circular No. SEBI/HO/CFD/CFD-PoDl/P/CIR/2023/123 dated July 13, 2023, regarding change in Senior Management Personnel is given herein below:

S. No. Disclosure Requirement Details
1 Reason for change viz. appointment,re-appointment, resignation, removal,death or otherwise Resignation
2 Date ofappointment / re-appointment/cessation (as applicable)& term ofappointment / re-appointment Mr. Sanjay Kumar, Senior ManagementPersonnel of the Company’s MaterialSubsidiary viz Panacea Biotec PharmaLimited has ceased to be an employeefrom the close of business hours onMarch 31, 2024.
3 Brief profile (in case of appointment) Not Applicable
4 Disclosure of relationships betweendirectors (in case of appointment of adirector) Not ApplicableVinodDb

Panacea Biotec Ltd (CIN: L33117PB1984PLC022350) Registered Office : Ambala-Chandigarh Highway, Lalru – 140501, Punjab

Correspondence/Corporate office : B-1 Extn../G-3, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9015 Email: [email protected]

==> picture [142 x 65] intentionally omitted <==

In this regard, a copy of resignation letter is attached herewith as Annexure – A.

We hereby further inform that inadvertently there has been some delay in filing of disclosure and the same is sincerely regretted.

This is for your kind information and record please.

Thanking you, Sincerely yours, For Panacea Biotec Ltd.

Vinod Digitally signed by Vinod Goel Goel Date: 2024.04.29 17:22:11 +05'30' Vinod Goel Group CFO and Head Legal & Company Secretary

Panacea Biotec Ltd (CIN: L33117PB1984PLC022350) Registered Office : Ambala-Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn../G-3, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9015 Email: [email protected]

Annexure -A